Myoepithelial neoplasms of soft tissue represent a heterogeneous group of lesions, encompassing both benign entities as myoepithelioma (ME) and highly aggressive tumors as myoepithelial carcinoma (MEC). We describe a case of pediatric soft tissue MEC with peculiar features that may lead to misdiagnosis: congenital onset and presence of a benign component with predominant cystic structure. Few cases of congenital MEC have been reported, but the coexistence of MEC with ME is even more rare, accounting for less than 1% of myoepithelial tumors. Moreover, an extensive cystic appearance had never been described in either ME or MEC of soft tissue. Despite several predictors of poor prognosis, the patient has been showing a favorable clinical course since the administration of ICpE (ifosfamide, cisplatin, and etoposide) chemotherapy. This report provides valuable information in the differential diagnosis of cystic congenital tumors and supports a possible efficacy of adjuvant combined treatment for patients with localized disease after surgery.
Introduction
Myoepithelial neoplasms of soft tissue represent a heterogeneous group of lesions, encompassing benign entities as mixed tumor (MT), myoepithelioma (ME), and highly aggressive tumors as myoepithelial carcinoma (MEC). 1 In contrast to their salivary gland counterparts, they are extremely rare and have been characterized in detail only recently. 2 Previous studies showed that approximately 20% of myoepithelial tumors of soft tissue occur in children, with a high rate of malignancy (65%). 1, 3 Soft tissue MEC arise more frequently in the extremities and trunk, presenting as solid and well circumscribed masses. The diagnosis of malignancy is primarily based on cytologic atypia, in contrast with myoepithelial neoplasms of the salivary glands, where architectural findings prevail. Notably, MEC of soft tissue display an aggressive clinical course, with a local recurrence rate of 39% and a tendency to metastasize in 52% of affected patients. 3 Here we describe a rare case of soft tissue MEC with some exceptional features that may lead to misdiagnosis. These include congenital onset and the presence of a benign component with a predominant cystic structure.
Materials and Methods

Tissue Handling
Tissue samples were formalin-fixed, paraffin-embedded and 4-µm-thick sections were stained with hematoxylin and eosin. Immunohistochemistry was conducted in 2 automated stainers (Ventana-Benchmark, Tucson, AZ) and Leica Bond-III (Leica Microsystems, Wetzlar, Germany). Real-time polymerase chain reaction (PCR) technique was applied for detecting several fusion genes associated with the following tumors: PNET/Ewing (EWS-FLI1, EWS-ERG, EWS-ETV4), synovial sarcoma (SYT-SSX1, SYT-SSX2), congenital fibrosarcoma (ETV6-NTRK3), mesenchymal chondrosarcoma (HEY-NOCOA2), and undifferentiated sarcoma (CIC-DUX4, BCOR-CCNB3). 
Clinical History
A male newborn was delivered without complications after 38 + 3 weeks of pregnancy. During the first few days of life the baby displayed a right deviation of the head. Although prenatal ultrasound failed to show any anomaly, the physical examination revealed a palpable mass located in the right posterior cervical region. The patient underwent another ultrasound examination that documented a complex, predominantly cystic mass within the right paraspinal muscles of the neck. Thus, he was admitted to our hospital for a magnetic resonance imaging (MRI) examination that confirmed the presence of an extensively cystic mass with a mural solid nodule. The lesion possessed smooth margins and multiple septations within the cystic compartment and displayed contrast-enhancement of the solid component ( Figure 1A-C) . There was mass effect on the adjacent paraspinal muscles without an evident infiltrative pattern. Computed tomography did not show calcifications or osseous involvement ( Figure 1D ). No secondary lesions were detected by thoracic computed tomography scan, abdominal ultrasound, and brain MRI. Laboratory tests were also normal. After a multidisciplinary discussion, it was decided to proceed with surgery. Postoperative MRI of the neck documented the complete removal of the lesion. Since the tumor extended in close proximity of the excision margins, it was decided to administer adjuvant therapy. The patient was treated with 3 courses of chemotherapy with ifosfamide, cisplatin, and etoposide (ICpE regimen), which combine antineoplastic drugs active against cells of mesenchymal and epithelial origin. 4 Considering the local aggressiveness reported in the literature, we added radiotherapy (total dose 5040 cGy). Subsequently, he received 2 more chemotherapy courses (ICpE combination). One month after the last course of chemotherapy, complete remission was confirmed by MRI. Since then, the child has been disease free along the 12 months of follow-up.
Pathology Findings
The specimen consisted of a tan, well-defined mass, measuring 5 × 4 × 3 cm; the surface cut showed a multiloculated cystic lesion, with a solid nodule protruding into the cystic lumen. The microscopic examination revealed a peripheral fibrous pseudocapsule circumscribing multiple pseudocystic spaces, with the largest one partially filled by a solid mural nodule ( Figure 2A) . A homogeneous population of middle sized cells with oval nuclei, disperse chromatin, and scant cytoplasm was predominantly distributed in a sheet-like appearance along the walls of the pseudocysts ( Figure 2B ). The cells were immersed in an abundant hyalinized stroma, with focal myxoid changes. Conversely, the mural nodule harboured a solid proliferation of large epithelioid cells, with pleomorphic nuclei, coarse chromatin, prominent nucleoli, and scarce eosinophilic to clear cytoplasm ( Figure 2C ). A network of small vessels with hyalinized walls was also identified. Occasional satellite micronodules with the same characteristics were found along the cystic wall, in close proximity to the nodule. Unlike the previously described component, this second, atypical population had a high mitotic rate and a significant apoptotic index.
Most neoplastic cells were positive with S100 protein, CD99, vimentin, and INI-1, while glial fibrillary acid protein (GFAP) and epithelial membrane antigen (EMA) were expressed only focally (Figure 3 ). Cytokeratins 8 (CK8) and 18 (CK 18) showed extensive positivity, but CK7 and CK20 were negative. The lesion was also investigated for the presence of NUT (nuclear protein of the testis) protein, but it was found negative with the NUT-specific antibody. Overall, we did not find any differential expression of immunohistochemical markers between the 2 populations, with the exception of the S100 protein that showed a stronger and more diffuse stain in the morphologically benign component ( Figure 3E ). The research of several major recurrent chromosomal translocations in pediatric sarcomas was negative. The final diagnosis was MEC of soft tissue combined with cystic ME.
Discussion
Congenital tumors are extremely rare and it is often challenging to reach a definite prenatal diagnosis. Among them, peripheral neuroblastic tumors and germ cell tumors are by far the most common types. Nevertheless, soft tissue neoplasms constitute a significant part of congenital malignancies, mostly being vascular or fibroblastic tumors. The clinical approach to these lesions is primarily based on imaging, with tumor location, size, margins, and growth pattern representing the most relevant parameters.
Although little is known about the imaging features of soft tissue MEC, they have been usually described as solid masses, exhibiting homogeneous or slightly heterogenous contrast enhancement. Sometimes they may show central necrosis, but they generally lack calcifications, fat and bone involvement. 5, 6 The present case displayed a peculiar radiological pattern, characterized by a prevailingly cystic appearance. The main differential diagnoses of childhood cystic or mixed solid-cystic lesions of the lateral neck include necrotic/infected lymph nodes or abscesses, branchial cleft cysts, vascular malformations, and neoplasms such as teratomas and vascular tumors. Given the congenital presentation, the absence of inflammatory signs, the lack of prominent vascular components, and the concomitant presence of cystic and solid structures, it is not surprising that the first radiological hypothesis leaned toward a congenital teratoma.
MEC of soft tissue has been increasingly characterized over the past 15 years, thus expanding our knowledge on its clinicopathological features. Despite its occurrence among both children and adults, it represents the vast majority of myoepithelial lesions of the pediatric population. 2 In the largest published series of pediatric soft tissue MEC (29 cases), boys and girls were almost equally affected. The age at diagnosis ranged from newborn to 17 years, and only 2 patients displayed congenital lesion. Most tumors were located in the extremities, but different anatomic regions were involved, including the head and neck. 3 The macroscopic appearance of soft tissue MEC may be quite variable, but most cases consist of well circumscribed solid masses, often with a thin pseudocapsule. Tumor size can range from several millimeters up to 20 cm in greatest axis, but MEC are usually larger than benign myoepithelial neoplasms. 1 They also exhibit a variety of macroscopic features in terms of color and consistency. 1, 3 Nonetheless, such an extensive cystic structure has never been reported in soft tissue myoepithelial tumors.
Heterogeneous features are seen also on histological examination, as MEC of soft tissue characteristically shows a wide spectrum of architectural and cytological features that can coexist in the same lesion. Neoplastic cells are arranged in variable growth patterns and embedded in a chondromyxoid or collagenous stroma. Although the present case did not display an overt cytological variability, tumors harboring more than one type of cell (ie, epithelioid, clear cell, spindle cell, plasmacytoid, rhabdoid) can be frequently encountered, with the epithelioid cells being the most common finding. In contrast to salivary glands, where the diagnosis of malignancy is based on architectural features, the distinction between benign and malignant myoepithelial tumors of soft tissue relies mainly on cytological atypia. Nonetheless, Hornick et al 1 showed that a high mitotic index and necrosis were common features of MEC. Unlike salivary gland neoplasms, the coexistence of ME and MEC is estimated in less than 1% of cases, thus representing an exceptionally rare finding. 2 This observation also suggests that soft tissue ME may underwent malignant transformation, as previously reported by Mahdi et al. 7 The immunohistochemical profile of soft tissue MEC shows significant differences from that of normal myoepithelial cells: despite the expression of several epithelial antigens, as broad-spectrum cytokeratins and/or EMA, soft tissue MEC often lacks myoepithelial markers. Conversely, both proteins S-100 and GFAP are expressed in most cases, whereas they are typically negative in nonneoplastic myoepithelial cells. Among myogenic markers, calponin is frequently positive (86%-100%), followed by smooth muscle actin (SMA) (36%-64%).
2 Soft tissue MEC is estimated to carry mutations of the tumor suppressor gene hSNF5/INI-1 (22q11.2) in 40% of the cases, but in the present case nuclear INI-1 expression was retained. 2 Interestingly, Gleason and Fletcher found that 2 cases of soft tissue MEC out of 29 had loss of chromosome 22, while another had a EWSR1 (22q12) rearrangement, thus leading to the hypothesis that aberrations of the chromosomal region 22q may play a role in the pathogenesis of this tumor. 3 The present case did not show EWSR1 gene rearrangements, even if they are well documented in soft tissue myoepithelial tumors. According to Antonescu et al, up to 45% of them harbor EWSR1 gene rearrangements. 8 To date, several fusion partners have been identified, including PBX1 (1q23), ZNF444 (19q23), POU5F1 (6p21), ATF1 (12q13) and PBX3 (9q339). 2 The functional consequences of such rearrangements are still largely unknown, but it was hypothesized that different fusion genes products could be associated with specific morphologic features. 8 Owing to its histological and immunophenotypic heterogeneity, the differential diagnosis of MEC includes several entities, most notably, high-grade extraskeletal myxoid chondrosarcoma (ESMC), epithelioid malignant peripheral nerve sheath tumor (MPNST), poorly differentiated synovial sarcoma, epithelioid sarcoma, Ewing sarcoma/PNET, and metastatic undifferentiated carcinoma. The latter, together with ESMC, epithelioid MPNST and poorly differentiated synovial sarcoma were considered less likely in the current case because they are uncommon in infants, with an extremely rare congenital occurrence. Whereas both MEC and epithelioid sarcoma may present in pediatric patients. They grow as multinodular masses and share morphological features such as epithelioid cells, occasionally with spindle and rhabdoid elements. However, since epithelioid sarcoma typically displays infiltrative margins and does not express S-100 and GFAP, the diagnosis of MEC prevailed. The presence of nuclear INI-1 expression, which is lost in more than 90% of epithelioid sarcomas, further excluded such diagnosis. 9 Extraosseous congenital Ewing sarcoma/PNET is an exceedingly rare entity that also arises in the differential diagnosis with MEC. It shows prominent round cells features and immunohistochemical positivity for CD99. Notably, Ewing family tumors (EFTs) may also express pancytokeratins in approximately 30% of cases and show, albeit rarely, S-100 positivity. 10, 11 However, despite a convincing CD99 positivity, the present tumor did not display a uniform population of small, round, blue cells. Furthermore, PCR failed to detect here the most common fusion genes associated with EFTs, thus weakening such hypothesis. The use of a complete immunohistochemical panel was critical to rule out other alternative diagnoses. Thus indeed, the nuclear preservation of INI1, along with the lack of diffuse rhabdoid features, allowed us to exclude the possibility of a malignant rhabdoid tumor (MRT). Similarly, the diagnosis of NUT midline carcinoma (NMC), which may arise congenital in the head and neck, was ruled out because of the negative stain with the anti-NUT antibody. 12 In addition, the lesion demonstrated no evidence of squamous differentiation, neither focally, and the patient was having a less-aggressive clinical course compared with NMC.
Gleason and Fletcher 3 described 2 different groups of MEC from a clinical standpoint. The first were large deepseated lesions, often with a rapidly progressive clinical course. The second included smaller tumors located within the superficial soft tissue, with an initial indolent behavior but a final tendency to metastasize. 3 Overall, MEC seems to have a poorer prognosis in the pediatric population than in adults: the mortality rate was 43% (follow up 26 months) against 13% (follow up 50 months), respectively. 1, 3 Because of its rarity, consensus has not been reached on the use of adjuvant therapy both in localized and metastatic diseases. In 2014, Bisogno et al published the Italian experience on 7 patients affected by MEC (age 0.5-9.2 years). 4 Since ICpE combination proved its efficacy in 1 patient, the same chemotherapy regimen associated with radiotherapy was administered thereafter. Only 1 patient received another combination of chemotherapeutic drugs and died of disease after a lung relapse. Those who were treated with a combination of surgery, chemotherapy (ICpE), and radiotherapy were alive at the time of the study, with a median follow-up of 2.5 years. Despite several predictors of poor prognosis (pediatric onset, relatively large tumor size, deep location), the present case has been showing a favorable clinical course. Such observation could further support the efficacy of adjuvant combined treatment for patients with localized disease after complete surgical excision.
